SCHEMBL1586579

SCHEMBL1586579

CON=C(C)C1CC1c1ccccc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 2/20 0.50
HTR2A P28223 3/20 0.40
HTR2C P28335 3/20 0.40
HTR2B P41595 3/20 0.40
LPAR2 Q9HBW0 1/20 0.38
DPP4 P27487 1/20 0.37
TP53 P04637 1/20 0.36
MAPK1 P28482 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HPGD P15428 3/20 0.35
GAA P10253 3/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
GLA P06280 2/20 0.35
CASP1 P29466 2/20 0.35
CASP7 P55210 2/20 0.35
HSD17B10 Q99714 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11926873 1.00 SLC9A1 (0.50) SLC9A1HTR2AHTR2CHTR2BLPAR2
SCHEMBL11926877 0.83 HPGD (0.35) SLC9A1HTR2AHTR2CHTR2BMAPK1
SCHEMBL1586513 0.83 HPGD (0.35) SLC9A1HTR2AHTR2CHTR2BMAPK1
SCHEMBL11926874 0.82 SLC9A1 (0.43) SLC9A1HTR2AHTR2CHTR2BDPP4
SCHEMBL1586548 0.82 SLC9A1 (0.43) SLC9A1HTR2AHTR2CHTR2BDPP4
SCHEMBL27883749 0.81 SLC9A1 (0.47) SLC9A1HTR2AHTR2CHTR2BLPAR2
SCHEMBL1586522 0.77 MEN1 (0.42) MAPK1HPGDL3MBTL1MAPTMEN1
SCHEMBL11926875 0.77 MEN1 (0.42) MAPK1HPGDL3MBTL1MAPTMEN1
SCHEMBL1585911 0.76 SLC9A1 (0.60) SLC9A1HTR2AHTR2CHTR2BLPAR2
SCHEMBL1586222 0.74 L3MBTL1 (0.32) SLC9A1HPGDL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488501-B1 NOVEL MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2014-04-30 EP disclosed
US-8357635-B2 Microbiocides SYNGENTA CROP PROTECTION LLC (US) 2013-01-22 US disclosed
EP-2488501-A1 NOVEL MICROBIOCIDES Syngenta Participations AG (CH) 2012-08-22 EP disclosed
US-20120202867-A1 NOVEL MICROBIOCIDES SYNGENTA CROP PROTECTION LLC (US) 2012-08-09 US disclosed
WO-2011045355-A1 NOVEL MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2011-04-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202867-A1 NOVEL MICROBIOCIDES CD14, FPR1, MPO SLC9A1 1626/4885HTR2A 3763/4885HTR2C 3036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.